Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00860535
What this trial is testing

Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)

Who this might be right for
Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML)Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
Merck Sharp & Dohme LLC 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07472868
What this trial is testing

Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Carcinoma
J. W. A. Burger 394
Testing effectiveness (Phase 2)Looking for participantsNCT07841236
What this trial is testing

CtDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer

Who this might be right for
Colon CancerDeficient Mismatch RepairMicrosatellite Instability-High (MSI-H)
Fudan University 23
Not applicableLooking for participantsNCT05416164
What this trial is testing

DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 595
Testing effectiveness (Phase 2)Study completedNCT00717405
What this trial is testing

Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 52
Large-scale testing (Phase 3)Study completedNCT00378222
What this trial is testing

Autologous Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Bologna 324
Testing effectiveness (Phase 2)Looking for participantsNCT07635342
What this trial is testing

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Hebei Medical University Fourth Hospital 182
Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Not applicableStudy completedNCT00342316
What this trial is testing

Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Vastra Gotaland Region 340
Not applicableStudy completedNCT00109525
What this trial is testing

Early Diagnosis of Candidiasis in Premature Infants

Who this might be right for
InfectionCandidaCandidiasis+4 more
NICHD Neonatal Research Network 1,500
Not applicableNot Yet RecruitingNCT07516626
What this trial is testing

Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast Cancer (LABC)
Atlas University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06764355
What this trial is testing

Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCCTotal Neoadjuvant TreatmentPathological Complete Response
National Taiwan University Hospital 50
Large-scale testing (Phase 3)UnknownNCT01134484
What this trial is testing

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Michele Cavo 480
Not applicableNot Yet RecruitingNCT05629442
What this trial is testing

CtDNA and Organ Preservation/Pathologic CR in Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Rectal Cancer
Massachusetts General Hospital 60
Not applicableLooking for participantsNCT04293796
What this trial is testing

Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)

Who this might be right for
Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
N.N. Petrov National Medical Research Center of Oncology 60
Not applicableUnknownNCT02348502
What this trial is testing

Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 160
Not applicableStudy completedNCT06630481
What this trial is testing

Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
Seoul National University Hospital 462
Testing effectiveness (Phase 2)UnknownNCT02885766
What this trial is testing

Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Fusion Pharma LLC 65
Testing effectiveness (Phase 2)Ended earlyNCT03872388
What this trial is testing

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

Who this might be right for
Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+17 more
M.D. Anderson Cancer Center 6
Early research (Phase 1)UnknownNCT04126590
What this trial is testing

Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun Intellicrown Pharmaceutical Co. LTD 39
Next Page